GLP-1 RAs Linked to Higher Hair Loss Risk - Takeaways - MDSpire

GLP-1 RAs Linked to Higher Hair Loss Risk

A large matched cohort study quantifies the association between glucagon-like peptide-1 receptor agonist use and nonscarring alopecia

  • By

  • Kerri Miller

  • February 19, 2026

  • 3 min

Share

  • 1

    GLP-1 receptor agonists (RAs) are linked to higher odds of nonscarring hair loss in adults compared to matched controls.

  • 2

    At 6 months, GLP-1 RA users had 1.62 times the odds of androgenetic alopecia and 1.26 times the odds of overall nonscarring hair loss.

  • 3

    By 12 months, the odds increased to 1.76 for telogen effluvium, 1.64 for androgenetic alopecia, and 1.40 for overall nonscarring hair loss.

  • 4

    The study highlights a rising incidence of nonscarring hair loss among GLP-1 RA users from 2014 to 2024, diverging trends noted from 2019.

  • 5

    Researchers emphasize the need for awareness of alopecia risk in GLP-1 RA patients for early detection and call for further research.

Original Source(s)

GLP-1 RAs Linked to Higher Hair Loss Risk

  • by Kerri Miller

  • February 19, 2026

Related Content

Low-Dose Oral Minoxidil Monitoring Questioned

A retrospective hair clinic study found stable blood pressure, heart rate, weight, and laboratory measures during follow-up of up to 30 months.

Reversing Epigenetic Changes in Skin Aging to Enhance Longevity Across Various Ethnicities and Skin Types with a Dihydromyricetin-Enriched Serum: Findings from a Prospective Cohort Investigation

Medical Oddities: Tattoos and Teeth Share Work Struggles

From unexpected workplace parallels to kitchen-counter experiments and a few clinical twists, this set of stories covered more ground than your average shift.